Pulmonology
Scope & Guideline
Leading the way in open-access research for respiratory disorders.
Introduction
Aims and Scopes
- Respiratory Diseases and Conditions:
The journal covers a broad spectrum of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, lung cancer, and infectious diseases such as tuberculosis and COVID-19. - Innovative Diagnostic and Therapeutic Approaches:
Research articles often explore novel diagnostic tools and therapeutic strategies, including the role of biomarkers, imaging techniques, and advancements in respiratory therapies such as non-invasive ventilation and pharmacological treatments. - Public Health and Epidemiology:
The journal emphasizes the public health aspects of respiratory diseases, including epidemiological studies that assess disease prevalence, risk factors, and health inequities associated with lung diseases. - Patient-Centered Care and Quality of Life:
There is a strong focus on studies that evaluate patient-reported outcomes, quality of life, and the impact of respiratory conditions on daily living, aiming to enhance the management and rehabilitation of patients. - Multidisciplinary Approaches:
The journal encourages interdisciplinary research, integrating insights from pulmonology, oncology, infectious diseases, and rehabilitation, reflecting the complex nature of respiratory health.
Trending and Emerging
- COVID-19 Related Research:
A significant increase in studies related to COVID-19 has been observed, encompassing aspects such as respiratory management, long-term sequelae, and the impact of the pandemic on lung health. - Personalized Medicine in Respiratory Care:
There is a growing emphasis on personalized medicine, with research focusing on tailoring treatments based on genetic, phenotypic, and environmental factors, particularly in conditions like asthma and COPD. - Telemedicine and Remote Monitoring:
The rise of telemedicine, especially in the context of COVID-19, has led to increased research on remote monitoring tools and their effectiveness in managing chronic respiratory diseases. - Environmental Impact on Respiratory Health:
Emerging studies are increasingly addressing the effects of environmental factors, such as air pollution and indoor air quality, on respiratory diseases, reflecting a broader public health perspective. - Multidisciplinary Management Approaches:
Research is trending towards multidisciplinary approaches in managing complex respiratory conditions, highlighting the importance of collaboration among various healthcare professionals.
Declining or Waning
- Tuberculosis Research:
Although tuberculosis remains a critical public health issue, recent publications indicate a declining focus on traditional TB research compared to emerging diseases like COVID-19. - Classic Respiratory Therapies:
There is a noticeable waning interest in traditional respiratory therapies, such as standard inhalation treatments, as newer modalities and personalized medicine approaches gain traction. - Epidemiological Studies on Historical Data:
Research centered on historical epidemiological data regarding respiratory diseases is becoming less common, as the focus shifts towards real-time data analysis and responses to current health crises. - Basic Science Research:
There seems to be a decrease in basic science studies that do not directly translate into clinical practice, as the journal emphasizes applied research and immediate clinical relevance. - Longitudinal Studies on Established Treatments:
The frequency of longitudinal studies analyzing long-term outcomes of established treatments has declined, possibly due to the rapid development of new therapies and a focus on immediate clinical trials.
Similar Journals
Egyptian Journal of Bronchology
Transforming insights into action for better respiratory care.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
RESPIROLOGY
Pioneering Research for a Breath of Fresh AirRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
BMC Pulmonary Medicine
Championing unrestricted access to vital pulmonary research.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Exploring innovative solutions for better patient outcomes.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
EUROPEAN RESPIRATORY JOURNAL
Championing Breakthroughs in Lung HealthThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Enhancing clinical outcomes through impactful research.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
Tuberculosis and Respiratory Diseases
Advancing knowledge in respiratory health.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
Annals of Thoracic Medicine
Exploring innovations in cardiology and pulmonary medicine.Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.
BMJ Open Respiratory Research
Advancing respiratory health through innovative research.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Respiratory Medicine and Research
Empowering professionals with cutting-edge findings.Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.